A second generation cervico-vaginal lavage device shows similar performance as its preceding version with respect to DNA yield and HPV DNA results

[1]  C. Westhoff,et al.  The acceptability of a self-lavaging device compared to pelvic examination for cervical cancer screening among low-income women. , 2012, Journal of women's health.

[2]  Y. Qiao,et al.  EUROGIN 2011 roadmap on prevention and treatment of HPV‐related disease , 2012, International journal of cancer.

[3]  G. N. Boer,et al.  Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  X. Yi,et al.  Improved sensitivity of vaginal self‐collection and high‐risk human papillomavirus testing , 2012, International journal of cancer.

[5]  J. Berkhof,et al.  Experience with high‐risk human papillomavirus testing on vaginal brush‐based self‐samples of non‐attendees of the cervical screening program , 2012, International journal of cancer.

[6]  E. Lazcano-Ponce,et al.  Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial , 2011, The Lancet.

[7]  A. Anttila,et al.  Self-sample HPV Tests As an Intervention for Nonattendees of Cervical Cancer Screening in Finland: a Randomized Trial , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[8]  E. Wilander,et al.  Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study , 2011, British Journal of Cancer.

[9]  A. Anttila,et al.  Self‐sampling versus reminder letter: Effects on cervical cancer screening attendance and coverage in Finland , 2011, International journal of cancer.

[10]  W. Melchers,et al.  The potential role of self‐sampling for high‐risk human papillomavirus detection in cervical cancer screening , 2011, Reviews in medical virology.

[11]  Veerle M.H. Coupé,et al.  Combined Promoter Methylation Analysis of CADM1 and MAL: An Objective Triage Tool for High-Risk Human Papillomavirus DNA–Positive Women , 2011, Clinical Cancer Research.

[12]  J. Waller,et al.  HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial , 2011, British Journal of Cancer.

[13]  G. Grazzini,et al.  The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600) , 2010, British Journal of Cancer.

[14]  Johannes Berkhof,et al.  HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study , 2010, BMJ : British Medical Journal.

[15]  J. Cuzick,et al.  Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. , 2010, The Lancet. Oncology.

[16]  Feng Chen,et al.  A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. , 2008, The Lancet. Oncology.

[17]  J. Berkhof,et al.  Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening , 2008, British Journal of Cancer.

[18]  D. Stewart,et al.  Self-collected samples for testing of oncogenic human papillomavirus: a systematic review. , 2007, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[19]  E. Franco,et al.  Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. , 2007, Gynecologic oncology.

[20]  J. Berkhof,et al.  Human papillomavirus testing on self‐sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs , 2007, International journal of cancer.

[21]  J. Habbema,et al.  Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands , 2006, International journal of cancer.

[22]  A. Castelo,et al.  Primary screening for cervical cancer through self sampling , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[23]  J. Berkhof,et al.  High Concordance of Results of Testing for Human Papillomavirus in Cervicovaginal Samples Collected by Two Methods, with Comparison of a Novel Self-Sampling Device to a Conventional Endocervical Brush , 2006, Journal of Clinical Microbiology.

[24]  J. Fitzgerald,et al.  Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis , 2005, Sexually Transmitted Infections.

[25]  J. Peto,et al.  The cervical cancer epidemic that screening has prevented in the UK , 2004, The Lancet.

[26]  J. Cuzick,et al.  Benefit of cervical screening at different ages: evidence from the UK audit of screening histories , 2003, British Journal of Cancer.

[27]  P. Snijders,et al.  GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes , 2002, Journal of Clinical Microbiology.

[28]  M Arbyn,et al.  Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. , 2000, European journal of cancer.

[29]  K Sigurdsson,et al.  The Icelandic and Nordic cervical screening programs, Trends in incidence and mortality rates through 1995 , 1999, Acta obstetricia et gynecologica Scandinavica.

[30]  P. Babb,et al.  Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. , 1999, BMJ.

[31]  J. Cuzick,et al.  Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. , 2012, The Lancet. Oncology.

[32]  E. Franco,et al.  BMC Women's Health , 2004 .